Chimera Investment Corporation (CIM)
NYSE: CIM · Real-Time Price · USD
13.31
+0.09 (0.68%)
Aug 7, 2025, 4:00 PM - Market closed
MorphoSys AG Stock Forecast
Stock Price Forecast
The 2 analysts that cover MorphoSys AG stock have a consensus rating of "Buy" and an average price target of $15.5, which forecasts a 16.45% increase in the stock price over the next year. The lowest target is $15 and the highest is $16.
Price Target: $15.50 (+16.45%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MorphoSys AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | +20.21% | Jul 10, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Hold Maintains $17 → $15 | Hold | Maintains | $17 → $15 | +12.70% | Jul 10, 2025 |
| UBS | UBS | Hold → Strong Buy Upgrades $12 → $15 | Hold → Strong Buy | Upgrades | $12 → $15 | +12.70% | May 14, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 23, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Hold Maintains $15 → $16 | Hold | Maintains | $15 → $16 | +20.21% | Aug 8, 2024 |
Financial Forecast
Revenue This Year
329.33M
from 277.89M
Increased by 18.51%
Revenue Next Year
342.12M
from 329.33M
Increased by 3.88%
EPS This Year
1.86
from 1.10
Increased by 68.95%
EPS Next Year
1.95
from 1.86
Increased by 4.89%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 353.4M | 372.2M | 386.8M |
| Avg | 329.3M | 342.1M | 355.0M |
| Low | 309.3M | 316.5M | 327.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 27.2% | 13.0% | 13.1% |
| Avg | 18.5% | 3.9% | 3.8% |
| Low | 11.3% | -3.9% | -4.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.17 | 2.10 | 2.32 |
| Avg | 1.86 | 1.95 | 2.13 |
| Low | 1.69 | 1.82 | 1.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 97.6% | 13.0% | 19.0% |
| Avg | 68.9% | 4.9% | 9.1% |
| Low | 53.2% | -1.9% | 0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.